Expanding the medical physicist curricular and professional programme to include Artificial Intelligence by Zanca, F. et al.
Physica Medica 83 (2021) 174–183
Available online 31 March 2021
1120-1797/© 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
Expanding the medical physicist curricular and professional programme to 
include Artificial Intelligence 
F. Zanca a,*,1, I. Hernandez-Giron b, M. Avanzo c, G. Guidi d, W. Crijns e, O. Diaz f, G.C. Kagadis g, 
O. Rampado h, P.I. Lønne i, S. Ken j, N. Colgan k, H. Zaidi l, G.A. Zakaria m, M. Kortesniemi n 
a Palindromo Consulting, Leuven, Belgium 
b Leiden University Medical Center (LUMC), Radiology Department, Albinusdreef 2, 2333ZA, Leiden, the Netherlands 
c Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Department of Medical Physics, 33081 Aviano, PN, Italy 
d Medical Physics, Az.Ospedaliero-Universitaria di Modena, Modena, Italy 
e Department Oncology, Laboratory of Experimental Radiotherapy, KU Leuven and Department of Radiation Oncology, UZ Leuven, Belgium 
f Faculty of Mathematics and Computer Science, University of Barcelona, Barcelona, Spain 
g 3DMI Group, Department of Medical Physics, School of Medicine, University of Patras, GR 265 04, Greece 
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A B S T R A C T   
Purpose: To provide a guideline curriculum related to Artificial Intelligence (AI), for the education and training of 
European Medical Physicists (MPs). 
Materials and methods: The proposed curriculum consists of two levels: Basic (introducing MPs to the pillars of 
knowledge, development and applications of AI, in the context of medical imaging and radiation therapy) and 
Advanced. Both are common to the subspecialties (diagnostic and interventional radiology, nuclear medicine, 
and radiation oncology). The learning outcomes of the training are presented as knowledge, skills and compe-
tences (KSC approach). 
Results: For the Basic section, KSCs were stratified in four subsections: (1) Medical imaging analysis and AI Basics; 
(2) Implementation of AI applications in clinical practice; (3) Big data and enterprise imaging, and (4) Quality, 
Regulatory and Ethical Issues of AI processes. For the Advanced section instead, a common block was proposed to 
be further elaborated by each subspecialty core curriculum. The learning outcomes were also translated into a 
syllabus of a more traditional format, including practical applications. 
Conclusions: This AI curriculum is the first attempt to create a guideline expanding the current educational 
framework for Medical Physicists in Europe. It should be considered as a document to top the sub-specialties’ 
curriculums and adapted by national training and regulatory bodies. The proposed educational program can be 
implemented via the European School of Medical Physics Expert (ESMPE) course modules and – to some extent – 
also by the national competent EFOMP organizations, to reach widely the medical physicist community in 
Europe.   
1. Introduction 
Over the years, the amount of information gathered in the healthcare 
enterprise has dramatically increased. The data explosion reached 
clinical and biomedical disciplines, including imaging, laboratory, ge-
netic, physiological, pharmaceutical, and structured clinical data, as 
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well as unstructured text-based records, and the related health infor-
mation generated with it. Clinical data are increasingly appended by 
digital health-related data from other sources too, like home-based or 
wearable healthcare electronic devices for vital signs or physical activity 
data retrieval [1,2]. 
This data volume increases demands for large storage space in PACS, 
databases and hardware for their processing, analysis, archiving, and 
management. Due to the growing amounts of 3D imaging exams per-
formed in modern radiology departments, around 50% of radiologists’ 
working time is spent on reviewing CT exams alone, and the rates of 
radiologists’ burnout are concerningly escalating [3]. This data- 
intensive outburst and the crushing imaging reporting workload 
cannot be handled by just means of human power. Hence, there is an 
apparent urgency for robust and reliable software that can support cli-
nicians, medical physicists and healthcare professionals in their tasks 
and Artificial Intelligence (AI) has been identified as a potential partner 
that can play a crucial role in this journey [4]. 
In parallel to the aforementioned changes to medical imaging, the 
evolution of computer hardware, even for desktop machines, has 
increased the number of users and developers of machine learning (ML) 
applications. High performance computing facilities based on computer 
clusters and cloud infrastructures are becoming more common. Com-
puter science applications have flourished taking advantage of these 
technological developments to provide the tools that can transform 
current healthcare processes to be more precise and efficient. Using this 
computational power, AI systems can mine the huge amount of digital 
data generated in healthcare today to build systems, that can take de-
cisions, make recommendations, make diagnosis or even predict pa-
tient’s outcome. Computing power will be a crucial factor in the 
evolution of AI-based applications together with the development of 
new architectures to optimize the current computational limitations 
towards quantum computing [5]. 
Current medicine aims at personalizing patient protocols. It also 
strives to be objective and quantitative to reach consistent and 
comparative results, expanding to parameters capable of describing 
treatment efficacy and care outcome. Therapeutic approaches to the 
individual patient demand the usage of various types of data, ranging 
from simple biochemical tests to more complex ones like histology or 
PET/MR data, for example. 
Working at the boundary between imaging science, informatics, and 
medicine, Medical Physicists (MPs) can play an important role in the 
implementation of AI in healthcare. Furthermore, for several specific 
tasks of the MP profession, such as quality control and planning in 
radiotherapy treatments, an integration process is underway with AI 
tools. As such, it is of paramount importance that MPs will broaden their 
active involvement in the healthcare community to ensure that their 
interdisciplinary knowledge brings maximal impact in this technological 
shift. 
The European Federation of Organisations for Medical Physics 
(EFOMP) shared its position on this topic, by publishing a white paper 
on Big Data and Deep Learning in medical imaging, in relation to the 
medical physics profession. Medical physicists must be prepared to face 
this transformational technology by updating their training and educa-
tion programs [1,6,7]. However, there is currently a lack of courses and 
workshops that are really tailored to the MPs needs. Within the aims of 
EFOMP, this kind of education could be imparted within the European 
School of Medical Physics Expert (ESMPE) course modules, which are 
organized regularly to provide basic and advanced training for MPs at an 
international level. 
To be up to the task in this scenario, EFOMP established in April 2019 
a new working group (WG) on AI in Medical Physicists [8]. The WG is 
formed by several MPs and experts from around EU from both diagnostic 
and therapeutic disciplines. The group has the objective of structuring 
an AI Curricular and Professional Program for MPs as well as to support 
the preparation of an ESMPE AI module. 
The aim of this paper is to report on the WG’s formulation of the 
European Curricular and Professional Program for MPs on AI. 
2. Material and methods 
2.1. The current role of medical physicists and future perspectives 
To understand the rationale and challenges for building a European 
Curricular and Professional Program on AI for MPs, we started from the 
role that the MPs play today and what would like to claim for the years 
to come. 
The overall goal of the MPs is to contribute to patient safety and 
secure the quality of care, as established in the 2013/59/Euratom 
directive [9]. Along with the introduction of more complex imaging 
modalities, computational methods and software applications in the 
medical field, there has also been a need to increase the skills of the MP 
to keep up with the technological expansion [1,10–13]. MPs’ expertise 
and tasks have focused on overall concepts of quality (including quality 
management (QM), quality assurance (QA), and quality control (QC) 
tests), safety (radiation dosimetry and safety, and electromagnetic safety 
issues), optimisation, as well as on research, development and evalua-
tion of new analytical techniques. 
To be successful in the provision of medical physics expertise on 
these general task areas, it is imperative that MPs working in the hospital 
environment are capable of combining thorough knowledge, practical 
skills and academic competence in a multi-professional medical com-
munity. This is also clearly stated in the EU RP174- which in turn is 
based on the Euratom Basic Safety Standards (BSS) Directive [14]- 
presenting European Guidelines on Medical Physics Expert and 
strengthening the importance of education and training as the founda-
tions of the MP profession [9]. 
While the focus of these two documents describing the role of MPs is 
on radiation protection and dosimetry, the EFOMP statement policy 16 
[15], elaborated on the BSS by expanding the role of the MP behind 
radioprotection and dosimetry, states that the MP needs “to ensure that 
medical radiological equipment (including radiation sources and software 
devices) in hospital is judiciously chosen according to the desired clinical 
outcomes, properly calibrated, quality controlled and very importantly used 
effectively, safely and efficiently for the good of the patient”. 
Indeed, in some countries, with the transposition of the BSS at na-
tional level states, the follow up of software tools that have an impact on 
the information content of an exam is already a legal task of the MPs [16]. 
It is in this spirit that the WG developed a curricular program for 
MPs, considering that the tasks of the “MPs 3.0” go beyond quality 
control, radiation protection and dosimetry. Moreover, they expand to 
clinical implementation, functional verification and validation, risk 
assessment, performance monitoring and optimisation, cost- 
effectiveness and up to a certain point, the research and development 
of AI-software as a Medical Device [13,17]. 
To build a meaningful and representative curriculum, the level of 
knowledge and experience on AI in diagnostic and therapy applications 
among European MPs needed to be assessed. For this reason, as a pre-
liminary step to develop the training content, an international survey 
among MPs was set. The survey was divided into three groups of ques-
tions: on the individual knowledge, thoughts and involvement of the 
responders with AI applications; on the needs, preferred learning format 
and content for the AI training course (which could be used to the design 
of an ESMPE module); and on demographic questions to investigate how 
responses vary between subgroups. The results of the survey recently 
reported [18], have been used for building the curriculum. 
2.2. Training program framework 
The method we used to develop the AI curriculum for MPs roots on 
previously published guidelines and EFOMP curricula [19–21] but ex-
pands on the new challenges and topics that have been brought to the 
profession by the AI arrival. In this sense, the proposed curriculum is to 
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be considered as an addendum to the previously published EFOMP core 
curricula for MPs in Nuclear Medicine (NM) (in 2013 [19]), Radiology 
(in 2011 [20]), and Radiotherapy [RT] (in 2011 [21]). 
We also aimed at developing a curriculum which is in line with the 
Bologna Declaration [22], and the recommendations from the European 
Parliament and the council of 23 April 2008, on the establishment of the 
European qualifications framework for lifelong learning [23]. 
As the depth of the MPs involvement with AI technologies will 
strongly depend on the speed with which they will be deployed in their 
countries and institutions, we have subdivided the curriculum in two 
levels, Basic and Advanced. The aim of this Basic training level is to 
introduce MPs to the pillars of knowledge, development and applica-
tions of AI, in the context of medical imaging and radiotherapy. The 
Advanced level instead aims at building on the knowledge acquired in 
the Basic and comprises common topics to the three current main sub-
specialties: (1) Diagnostic and Interventional Radiology, (2) Nuclear 
Medicine, and (3) Radiation Oncology. The lack of recent core curric-
ulum documents per subspecialty was a limitation during the prepara-
tion of the Advanced level training [19–22]. The Working Group 
approach was to create a common Advanced curriculum that could be 
further defined, in the future EFOMP core curricula for the three main 
subspecialties. Note that a fourth subspeciality for Advanced, “Others”, 
is proposed to comprise modalities and subjects not covered by the core 
curricula but for which the role of MPs is starting to increase, such as 
biophysics, physiological signal measurements and cardiology, to cover 
fields which will have AI applications in the future. However, this fourth 
category will not be expanded in this curriculum to cohere with the core 
curricula of EFOMP. 
Note that the advanced knowledge and competences required to 
develop in-house AI-software are considered out of scope for the present 
curriculum. These would correspond to a third “High level” and it is 
advised for MPs interested in this type of in-depth training, to look for 
the specific courses and training programs available outside of EFOMP. 
As a common methodology for both levels, the learning outcomes 
(LOs) of the training program were established, identifying the current 
and potential tasks that MPs can be involved with respect to AI in their 
work settings. For these definitions we followed the approach presented 
in the most recently published EFOMP curriculum for nuclear medicine 
[19]. The LOs were also translated into a syllabus of a more traditional 
format, including topics and potential practicals and resources (see 
Appendix). 
The learning outcomes are statements that describe three aspects: (1) 
Knowledge, (2) Skills and (3) Competence (KSC), that the students should 
acquire when successfully completing training at each one of the parts. 
In brief, these three aspects, in relation to the LOs were defined as:  
• Knowledge: Facts, principles theories and practices  
• Skills: Ability to use knowledge and know-how to complete tasks and 
solve problems (cognitive skills (logical, intuitive and creative 
thinking) and practical skills (use of methods, materials, tools and 
instruments))  
• Competence: Responsibility, management and autonomy. 
3. Results 
The general overview of the curriculum and its two levels are 
described in detail in the following sections. In Fig. 1 (Basic) and 2 
(Advanced) an overview of the levels that were used to define the cur-
riculum framework are reported. 
Note that in Fig. 2 (Advanced) we also list a possible stratification of 
sub-specialties and associated modalities, as we consider they should be 
addressed when revising the current core curricula. 
3.1. Basic level 
For the Basic level, LOs expressed as KSCs were stratified into four 
subsections that correspond to (1) Medical imaging analysis and AI 
basics (part II in Appendix), (2) Implementation of AI applications in 
clinical practice (part III in Appendix), (3) Big data and enterprise im-
aging (part IV in Appendix) and (4) Quality, Regulatory and Ethical Is-
sues of AI processes (part V in Appendix). Note that the list of practical 
applications (which would serve as input for a possible ESMPE school 
Fig. 1. Overview of the Medical Physicist curriculum framework for Artificial Intelligence: Basic level.  
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Fig. 2. Overview of the Medical Physicist curriculum framework for Artificial Intelligence: Advanced level (subspecialties).  
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module) is reported together with the syllabus, in the same Appendix. 
The list of the LOs for the Basic part of the curriculum is given in 
Tables 1–4, which correspond to the four subsections as defined above. 
3.2. Advanced level 
The learning outcomes for this common Advanced curriculum, 
shared by all subspecialties are presented in Table 5. 
Note that the skill set of any MP subspecialty needs to incorporate the 
QA aspects related to AI to help maintain acceptable quality and safety 
of diagnostics or care. We cannot emphasize enough how challenging it 
is to include the AI scope to the existing KSC set, taking into account that 
AI methods can be applied in basically every phase of the diagnostic or 
therapy process in healthcare. Therefore, current QA methods need to be 
improved, and in many cases new QA metrics or methods are required to 
encompass the performance and safety effects of AI [25]. 
Translating this to radiology would mean for example, proposing an 
in-silico QA methodology for assessing and benchmarking AI application 
in mammography, by means of generating hybrid (real and synthetic) 
images and through identification of quality metrics that impact the 
output of AI software tools for lesion detection and characterisation [26]. 
In a NM context this could be further elaborated by critically judging 
the relevance of the performed QA and QC programs integrated with 
molecular imaging and quantitative analysis software in diagnosis, 
prognosis and therapy, and integrating in them the necessary specific 
tests the performance tests of AI-support tools in terms of accuracy and 
safety [27,28]. 
In RT, knowledge-based treatment planning is an example of the appli-
cation where the impact of AI developments is obvious and where an updated 
QA process is needed to decrease outliers in treatment plans [29,30]. 
Table 1 
LOs for Basic Level: Medical imaging analysis and AI introduction.  
Knowledge 
List and comprehensive learning of:   
◦ basic AI terms and definition (including neural network parameters and machine 
learning (ML) problem types), differences between AI, machine learning, deep 
learning, and traditional Computed Aided Diagnosis (CAD)  
◦ image theory and image quantification principles, and image transformations 
(segmentation, registration, reconstruction)  
◦ basic statistics for model validation (sensitivity, specificity, accuracy etc., F1 score, 
Receiver Operating Characteristic (ROC) methods, confidence intervals (CI), etc).  
◦ popular tools, open data sets, available test sets, available languages and 
frameworks  
◦ high level process for AI applications development, validation and clinical 
implementation (use case definition, data access and curation, training/testing 
strategies, IT infrastructure requirements)  
Skills   
◦ use properly and accurately AI related terminology, distinguish between ML, DL 
and CAD applications and identify if one application is AI-based or not  
◦ perform tasks related to image processing by managing tools for image 
segmentation, Region of Interest/Volume of Interest (ROI/VOI) extraction, 
labelling, archiving, etc.. Assess the variability associated to different segmentation 
and VOI extractions methods (with manual, analytic algorithms and AI processes)  
◦ formulate, carry out and interpret simple multilayer neural network performance 
(hyperparameter optimization, train/testing strategies, generalization aspects, 
presentation of results, interpretability and explainability)  
◦ manage simple classification tasks, including strategies of train/test set divisions for 
validation purposes  
◦ use techniques for data retrieval, anonymization and labelling and be able to create 
datasets (including images as required) and check their suitability, as input for 
multilayer neural networks, applying data curation criteria  
Competences   
◦ identify the activities in own institution where MP could play a role in relation to AI  
◦ take responsibility for reinforcing an accurate use of AI related terminology among 
peers  
◦ be responsible of supporting in image processing tasks, such as image segmentation, 
labelling, in datasets to be used for AI validation and testing, etc.  
◦ contribute to educate AI basics to MPs and other MDs professionals.  
Table 2 
LOs for Basic Level: Implementation of AI applications.  
Knowledge 
List and comprehensive learning of:   
◦ open datasets and previous AI challenges, synthetic dataset characteristics and 
requirements, existing and available (pre-)trained networks and available software 
and computational platforms for data annotation and curation  
◦ basic IT infrastructure requirements for AI applications (GPU, High Performance 
Computing (HPC), external scientific computing services, cloud computing, hybrid 
computing solutions)  
◦ medical imaging data readiness levels (MIDaR) and annotation, labelling and 
segmentation methodologies for clinical applications  
◦ the principles of AI software as medical device management.  
Know how to:   
◦ evaluate clinical needs and preparation of technical specifications for tender 
purposes  
◦ deal with AI commercial solutions during procurement, commissioning, integration 
in clinical workflow and QA  
◦ process and critically analyze manufacturer specifications from AI applications, 
white papers, and other documentation  
◦ perform data retrieval, anonymization and labelling in clinical practice in a simple 
case study  
◦ develop prospective and/or retrospective validation studies for AI step by step also 
using case examples, in a multidisciplinary team  
Skills   
◦ study and extract relevant technical information related to AI software applications 
in scientific papers, white papers, reports and manufacturers documentation  
◦ prepare written documents and reports to share in a multidisciplinary team during 
procurement (including tender procedures), commissioning and/or integration on 
clinical workflow  
◦ support and advise on data curation for local validation and QA of AI commercial 
applications  
◦ validate and test (and potentially create) synthetic datasets for AI-validation and in 
silico trials  
◦ participate and provide support during procurement, commissioning and/or 
integration in clinical workflow of AI applications, including the implementation of 
related QA programs  
◦ perform data retrieval, anonymization and labelling in clinical practice in a simple 
case study  
◦ participate as a MP member in a multidisciplinary team in development of 
prospective and/or retrospective validation studies blueprint (data retrieval, 
anonymization and labelling in clinical practice) in a simple study for AI step by 
step using case examples  
◦ evaluate critically MIDaR for AI validation databases in a simple clinical study.  
Competences   
◦ master the definition of technical specifications and requirements for the 
procurement and commissioning of commercial AI software applied to medical data  
◦ communicate:   
• relevant technical information provided by the AI manufacturer and write 
reports or other useful materials to be used during commissioning and 
acceptance.  
• results to peers (in the form of notebooks, notes, resumes, reports, poster, article, 
oral presentation) at institutional, national and international meetings and for 
research journals.   
◦ oversee, where appropriate as a member of a multidisciplinary team:   
• infrastructures for display and reading of images and for the reporting and 
archiving of findings for AI clinical validation.  
• the acceptance, commissioning into clinical use, and in-house validation of 
commercial AI software applied to medical data, including data access, selection 
and curation, handling multi-dimensional datasets  
• performance assessment and tracking (QA) of AI software  
• the potential role of phantom studies in the implementation, validation, QA 
program and/or follow up performance of AI software  
◦ advise on potential pitfalls of in-house (including combining databases from 
different machines or vendors) and multi-centre validation of AI software  
◦ propose medical physics sessions as part of education and training of AI 
applications to medical data and take responsibility on the training of other MPs 
and other professionals in relation to AI medical applications  
◦ read and analyse critically international literature and participate/organise 
networks for research, benchmark and development of AI applications to medical 
data within own scientific community.  
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4. Discussion 
This curriculum is intended as a guideline to incorporate Artificial 
Intelligence to the training of MPs in Europe and associated countries 
under the EFOMP umbrella. During the initial phase of this WG activities, 
a pilot online international survey with AI-specific questions was pre-
pared and distributed among the MPs community [18]. In total, 219 
participants from 31 countries provided their answers and the majority of 
them (88%) agreed with the statements “Medical Physicists need specific 
training on AI” and (80%) with the statement “I strongly believe that AI 
should be part of the medical physicists curriculum”. In the present 
curriculum, we included and privileged the topics that obtained a higher 
score in terms perceived importance and impact of AI in the profession (e. 
g. basic AI, QC applications, integration of AI in clinical workflow). 
The AI curriculum presented in this publication reflects our present 
understanding of the current stage of the rapidly evolving AI field and 
how it is reflected in the MPs profession in terms of KSCs. 
The first level of training (Basic) is intended to give a broad overview 
of the fields where the role of MP will become relevant and needed for 
the deployment of AI in healthcare. The justification of this level is to 
provide common foundations for all MPs enrolling and to cement the 
general KSCs required to deal with AI technologies in their routine 
present and future practice, also avoiding biases and potential differ-
ences between all EFOMP country members. 
The second level of training (Advanced), focused on the MP sub- 
specialities [9], shares common content across the subspecialties, indi-
cating that similar blocks of knowledge are needed in different fields of 
medical physics. The lack of update of the EFOMP core curricula for 
subspecialties [19–21] represented a challenge in the creation of this 
document. The contents of this section need to eventually lean on and 
align with those documents and thus, would potentially need to be 
reviewed in the future when updated core curricula will be released [8]. 
A potential third level of training (High level), related to the devel-
opment of in-house AI-based tools by MPs, has been described briefly 
and in more general terms at the beginning of this document. This WG 
considered this out of the scope as the number of MPs involved in the 
development of AI tools themselves is still low, and mostly limited to 
university hospitals and research activities. 
As we are aware, the field of AI in general and its implementations in 
medicine are still taking shape because even the basic AI architectures 
along with data sharing capabilities (also in legal and ethical aspects 
[31]) are still in relatively early development. Therefore, our proposed 
curriculum has been formed as a consensus to reflect the present need 
Table 3 
LOs for Basic level: big data and enterprise imaging (EI).  
Knowledge 
List and comprehensive learning of:   
◦ basic principles, existing standards and platforms, data mining techniques and 
radiomics and imaging biobanks for enterprise imaging  
◦ describe the main requirements for transparent reporting on multivariable 
prediction models (TRIPOD statement and checklist [24])  
◦ key performance indicators definition for big data information analysis 
Know how:   
◦ to benchmark, validate and curate data coming from different sources in the big 
data enterprise solution  
◦ to define and personalize dashboards in the enterprise solution interface, in 
function of the user (MPs, radiologists, oncologists, administrative staff, etc.)  
◦ to process and critically analyse manufacturer specifications white papers, and 
other relevant documentation for EI solutions  
Skills   
◦ critically read vendor and other related documentation and identify potential 
pitfalls and solutions during implementation phase and the integration in the 
clinical workflow in the EI context  
◦ critically revise data mining techniques performance and output  
◦ define the requirements, construct and validate (consistency check of) datasets as 
input for radiomic studies  
◦ check the robustness of radiomic features and the potential role of harmonization 
methods based on AI  
◦ be familiar with standardization initiatives for biomarkers and radiomics [25]  
Competences   
◦ communicate relevant technical information provided by the AI manufacturer and 
write reports or other useful materials to be used during commissioning and 
acceptance.  
◦ in a multidisciplinary team, oversee:   
• the acceptance and commissioning into clinical use of EI software applied to 
medical data  
• in-house validation studies, including the data access, selection and curation, 
handling multi-dimensional datasets working in a multidisciplinary team  
◦ communicate clearly results to peers at local and international meetings and for 
research journals on radiomics studies or AI study (in the form of notebooks, notes, 
resumes, reports, poster, article, oral presentation). 
◦ advise on possibilities and potential pitfalls in in-house (including combining da-
tabases from different machines or vendors) and multi-centre validation of radio-
mics features  
◦ take responsibility for the training of other MPs and other professionals in relation 
to radiomics-based AI medical applications and propose medical physics sessions as 
part of education and training of radiomics applications to medical data  
◦ critically analyse international literature within a given area of research about 
radiomics applied to medical data and participate/organise networks for research 
and development of these applications within own scientific community.  
Table 4 
LOs for Basic Level: Quality, Regulatory and Ethical Issues of AI processes.  
Knowledge   
◦ list legal, ethical aspects and challenges at national and international level about 
the use of AI applications  
◦ explain the process leading to CE marking:   
• terms used for European (CE) and US (FDA) AI software approval process and 
regulation  
• the current regulation for AI software as a medical device for commercial and in- 
house use software  
• the meaning of ‘acceptability criteria’ as applied to AI software as medical 
devices  
◦ describe the main aspects of national and international law (including General Data 
Protection Regulation, GDPR) about privacy related to the use of medical data in AI 
processes  
Skills   
◦ evaluate if a specific AI software is GDPR compliant  
◦ evaluate and participate in the preparation of documents for ethical committees’ 
approval  
◦ organize data flow and analyze data safety, security and privacy regulations in AI 
applications and infrastructure (including clinical trials, in a multidisciplinary 
team)  
◦ design and test physical and technical methods for quality control of data input to 
AI systems in standardise QA programs, including clinical trials (in a 
multidisciplinary team)  
◦ autonomously acquire, critically assess and extract relevant information from AI 
manufacturers user/technical specifications, literature and other documentation 
related to their clinical evidence generation and compare with results in literature. 
Communicate such information to peers in the form of reports or other 
documentation.  
◦ promote and implement the basic safety standards, guideline defined in the 
national and international legislation applicable to AI via technical and clinical 
audit to observe, manage and mitigate AI use correlated potential risks.  
Competences   
◦ take responsibility for AI device management including evaluation of intended use, 
compliance to national and international regulations, risk analysis, compliance 
with GDPR, and HIPAA (Health Insurance Portability and Accountability Act) when 
dealing with countries outside EU, in a multi-disciplinary team  
◦ take responsibility for assessing post-market surveillance of a CE marked device 
integrated in clinical workflow  
◦ take initiative, when needed and relevant, to further testing FDA/CE market tools in 
real/different clinical context other than the one used for regulatory process  
◦ use the methodologies of Health Technology Assessment (HTA) to carry out a HTA 
of an AI device in conjunction with other healthcare professionals.  
◦ organize and manage quality control teams in own areas of Medical Physics AI 
applications  
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for training and education content in this area but many parts in the 
curriculum should be reviewed regularly to keep it updated. Specif-
ically, we acknowledge that the technology of AI is rapidly evolving and 
that was the justification to emphasize the main pillars on the Basic 
training level and to limit the curriculum and the KSCs to more common 
items in the Advanced level (Appendix). 
Nevertheless, the fast development of the AI field implies that many 
advanced aspects of AI training for MPs should be resilient and adapt-
able. It is obvious that the field of AI is driving a major transformation in 
the present time and also in the future, which makes it challenging to 
envision how fast some of our tasks as MPs will have to change and 
adapt. This does not indicate that we are in a position to await how AI 
unfolds, but rather that MPs should start to own their future roles and 
involvement in AI deployment in healthcare, and prepare via training 
for the future ahead. 
The traditional role of MPs includes important aspects of quantita-
tive methods, which serve as a source of reference in the development 
and implementation of AI in the clinical field. We could call this the 
metrology of information and Big Data. The automated objective eval-
uation of the quality of the images that are generated, the traceability of 
imaging and treatment protocols among equipment, departments and 
hospitals will need the active engagement of MPs to help safeguard the 
integrity and robustness of the generated patient data, working side by 
side with other healthcare colleagues. This is due to the fundamental 
need of the continuously learning AI systems to have reliable and 
curated ground truth information regularly brought in to keep the DL 
networks updated. 
In the future, it is more likely that the current medical physics sub-
specialities (radiology, nuclear medicine, radiotherapy and potentially 
new ones) will be increasingly merged together in the context of 
comprehensive diagnostic-care chains and outcome driven processes in 
healthcare. In that continuum, the AI methods fit well as comprehensive 
tools to drive effective medical decision-making but also the intermediate 
steps along that path must be reliably managed and assured. Otherwise, 
the outcome is not reliable for safe, cost-effective and high-quality care. 
Those intermediate steps can also be regarded as checkpoints where MP 
knowledge and role are pivotal to have reliable, quantitative and objec-
tively determined reference values for the QA and continuous learning 
labels required by the AI systems. Medical Pysicist training and knowl-
edge is a combination of physics, informatics and medicine, including 
long experience on clinical environment and practices. This combined 
information is also needed to build bridges across the clinical and IT 
professions, and for the understanding of the underlying issues of tech-
nology which may induce caveats in patient safety and quality of care if 
they are not properly accounted for. MP role in the future medicine is 
therefore even more pronounced, with emerging AI applications, as the 
gatekeeper of safety and quality and a crucial linchpin in healthcare 
between radiologists (and other medical professionals using AI-based 
tools), computer scientists, AI developers and IT professionals. 
5. Conclusions 
This curriculum is the first attempt to create a guideline to extend the 
education of MPs in Europe in relation to the emergence of AI in 
healthcare. It is the result of the discussions within an international WG 
and builds on previous regulations. The WG has made an initial proposal 
related to the potential responsibilities of MPs with regard to AI appli-
cations with an effect on their role. Yet, there is a need for a wider 
discussion for our profession in this regard, encouraged and led by our 
MP professional societies. 
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Appendix 
EFOMP AI Working group curriculum for medical physicists 
Note that practical examples were incorporated in the basic level 
curriculum only, in order to provide concrete cases to demonstrate the 
main methods and tools in AI which are essential to facilitate deeper 
understanding of the AI principles, and therefore, to build knowledge. 
On the other hand, practical examples were not explicitly presented 
in the advanced level curriculum because the advanced level is entirely 
already related to practical applications, with their development and 
implementation in the main sub-specialities and within their various 
modalities. Therefore, advanced level training should already be applied 
(mostly in practice) learning in all of its specific curriculum topics. 
Table 5 
LOs for Advanced Level (shared by all subspecialties).  
Knowledge 
Identify, describe, define:   
◦ advanced methods for QA of AI tools (including image quality assessment using 
model observers and other metrics related to the clinical task) in patient and 
phantom (physical and virtual) images  
◦ different uses of AI for image reconstruction, registration, noise and artifact 
reduction, filtering and transformation  
◦ AI methods for object/anatomical region/organs recognition, segmentation, and 
localization  
◦ the use of AI tools for optimization (dose monitoring, organ dose, organ 
recognition, patient positioning, contrast dose, automatic positioning of simulated 
radiation beams or radiopharmaceuticals on virtual phantoms)  
◦ the use of AI tools for management (workflow, hanging protocols, appropriateness 
and utilization, acquisition time)  
◦ the use of AI tools for big data mining (enterprise imaging platforms and 
governance)  
◦ AI applications for image harmonization for multi-centre studies, extraction of 
image biomarkers and building predictive/prognostic models  
Skills   
◦ perform calibration or model adjustment of the equipment, software, and QA 
programs according to the clinical and research use of AI tools  
◦ develop and implement advanced image quality metrics framework in patient and 
phantom QA studies  
◦ use software suitable for AI basic processes and relative libraries  
◦ evaluation of a simple multilayer neural network performance including 
generalization aspects, presentation, interpretation and explanation of results  
◦ take corrective measures of QA and model including interruption of AI system if 
hazard for patients and/or workers could appear.  
Competences:   
◦ critically evaluate and improve the performed QA and QC programs, in cooperation 
with other healthcare professionals when required  
◦ coordinate and/or participate in a research project on the use of AI for image 
restoration/reconstruction, automated diagnosis, disease or tissue characterization 
or outcome prediction  
◦ project optimization study for effective use of AI reconstruction methods  
◦ implement a pipeline to extract image biomarkers and building predictive/ 
prognostic models using AI  
◦ to automate the patient dose registry or archive managements and to prevent 
potential overexposures  
◦ plan processes regarding AI adverse events, such as mismatch and misdiagnosis or 
mistreatment in use of AI model for trials in radiology, radiotherapy, molecular 
imaging  
◦ support for the correct management of processes for obtaining patients’ informed 
consent for diagnostic and therapeutic procedures, where AI is used for trials or 
clinical practice (i.e. outcome prediction)  
◦ support and advise on regulatory roadmap for in-house or commercial use of AI 
applications (intended use, risk categorization, verification and validation, clinical 
evidence, post-market surveillance)  
◦ support vendors in their regulatory process for an AI medical device in terms of data 
curation and clinical evidence generation, in the context of a partnership project  
F. Zanca et al.                                                                                                                                                                                                                                   
Physica Medica 83 (2021) 174–183
181
BASIC LEVEL 
PART I: INTRODUCTION 
1. The strategic role, competence and education of medical phys-
icist in the era of AI 
a. The philosophy of AI: Hype vs reality, era of changes, opportu-
nities for the future  
b. MP role for the integration of (commercial) AI-based tools in the 
clinical workflow and in the research context  
c. Proper use of AI terminology 
PART II: TECHNOLOGY: THE PILLARS  
2. Medical Imaging analysis  
a. Image theory  
b. Image segmentation, registration and visualization  
c. Image quantification (inc. Radiomics’ based approaches)  
d. Image management for RT  
e. Image reconstruction  
f. Predictive models 
Practical: Image processing tools relevant for AI: Freeware tools applied to 
automatic 2D/3D segmentation, ROI/VOI extraction and features.  
3. Basics of machine learning (ML) and deep learning (DL) in 
imaging  
a. Machine learning in general: 
i. Justification: Ideology, terminology (e.g. underfitting/over-
fitting) and history of ML evolution  
ii. Formulating a problem as a ML problem 
1. Types of problems: function approximation, dimension-
ality reduction, anomaly detection, decision making / 
prediction, classification, regression  
2. Rationale behind using ML approach  
3. The importance of data curation  
4. Methods for data augmentation  
iii. ML classes: clustering algorithms, support vector machines 
(SVM), decision trees / random forest learnings, reinforce-
ment learning, and others.  
iv. Why to use Deep Learning? 
1. Differences between ML, DL and traditional CAD (com-
puter-aided diagnosis)  
2. Representative power of neural networks. Examples in 
medical imaging  
b. Deep learning as a subset of ML  
i. An overview of basic NN structure and various architectures 
with focus on convolutional neural networks (CNN). 
ii. Training a network and the standard terminology: loss func-
tion, regularization, underfitting/overfitting, stochastic 
gradient descent (SGD), batch, epoch, backpropagation, 
inference/prediction/forward pass, hyperparameter optimi-
zation, activation maps, data augmentation, adversarial 
training  
c. Validating your choice of network and the final results  
i. Terminology and common approaches (validation, train and 
test set division, class imbalance, cross-validation, confor-
mance to TRIPOD statement)  
ii. Basic statistics: sensitivity, specificity, accuracy (etc.), F1 score, 
Receiver Operating Characteristic (ROC), Area Under the ROC 
curve, confidence intervals (CI), statistical significance  
Practical  
◦ Hands-on: Jupyter notebook applied to simple classification problems, 
train-validation-test set division  
◦ Application of NN and DL models to a simple image segmentation task 
with a help of transfer learning: leveraging pre-trained models and 
adapting to new contexts, evaluating the results  
◦ Demonstration of hyperparameter optimization, the effect of different 
loss functions etc. on overfitting/underfitting and dying neurons. 
Visualization of activation, weights using TensorBoard. 
PART III: Implementation of AI applications in clinical practice  
4. Introduction on how to develop AI applications  
a. Use case definition  
b. Overview state of the art: open datasets, available (pre-)trained 
networks, previous challenges, available software and computa-
tional platforms for data annotation, curation, and AI applications 
development  
c. Accessing, curating and preparing imaging data: approaches and 
challenges:  
i. Medical imaging data readiness levels (MIDaR)  
ii. Pre-processing and harmonization methods  
iii. Annotation methodologies  
iv. Labeling and segmentation methodologies  
v. Reinforced learning and data  
vi. Multi-dimensional/-model data  
vii. Synthetic datasets and in-silico trials foundations 
d. What’s already out there? Open datasets, available trained net-
works (e.g. from previous challenges)  
e. IT infrastructure requirements (on-site/in the cloud): GPU, 
workstations, external scientific computing services, cloud 
computing, hybrid computing solutions 
Practical:  
◦ Demonstration of data retrieval, anonymization and labeling in 
clinical practice  
◦ Based on case studies: clinical study design and validation, ground 
truth, metric definition, training, validation, test of the dataset, 
observing validation loss/accuracy during training, overfitting etc., 
learning rate schedule, overall evaluation of the network perfor-
mance including generalization aspects, presentation of results. 
Explainability.  
◦ Getting started: Develop an AI tool based on a CNN configuration 
programming in Python and application to a simple simulated data 
set. Practical exercise on data curation and annotation using 
freeware software  
◦ Case examples how to set up IT infrastructures in general  
◦ Multiprofessional aspects: example of decision-making process of 
how to determine what data parameters to include in the data sets  
◦ Hands-on on a public set of data  
5. Role of the MP: how to deal with AI-based commercial solutions  
a. Procucrement of commercial AI software/applications  
b. Specifications: what information to expect from the AI vendor, 
white papers and other documentations/resources 
c. Implementation, resourcing, organizational validation, accep-
tance and commissioning into clinical use, education and training 
of radiologists and beyond 
d. Integration in clinical workflow: case examples of clinical vali-
dation with prospective and/or retrospective validation projects, 
preferably extending to multi-center examples 
Practical  
◦ Case studies: examples of vendor documentation with analysis of 
relevant/not relevant information  
◦ Evaluation of a new AI project implementation with possible 
problems and solutions  
◦ Experiments on the ACR lab -comprehensive overview of existing AI 
tools per specialty and related public results/trials/challenges 
PART IV: Big Data and Enterprise Imaging 
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6. What is enterprise imaging (EI)?  
a. Basic principles  
b. Existing standards and platforms  
c. How to define key performance indicators for leveraging big data 
information  
d. EI in the context of AI 
Practical:  
◦ Example case of vendor documentation with analysis of relevant/ 
not relevant information, evaluation of a new AI project imple-
mentation with possible problems and solutions - possible integra-
tion with PACS/RIS.   
7. Imaging Biomarkers and Radiomics  
a. Basics  
b. Overview of tools on the market for imaging biomarkers  
c. Standardization initiatives (e.g. IBSI)  
d. Imaging biobanks 
e. Radiomics workflow: data selection, acquisition protocol re-
quirements, VOI segmentation methods, features extraction and 
selection, internal and external validation 
f. Challenges for multi-centers radiomics studies: features robust-
ness analysis and AI support methods to harmonize data 
Practical: 
◦ Coronary artery calcium scoring (due to high relevance in health-
care, as the cardiovascular diseases are most prominent killers 
around the world population). 
PART V: Quality, Regulatory and Ethical Issues  
8. Policy and Privacy of data  
a. International Law and data exchange  
b. iCloud (case example)  
c. General data protection regulation (GDPR), and HIPPA when 
dealing with data from countries outside EU, i.e. USA. 
d. AI process, decision making and ISO 9004 certification stan-
dard - Disaster Recovery solution 
Practical:  
◦ Hands-on test to assess if a set of data is GDPR compliant  
◦ Use case: Lessons learned from hospital ethics committee report 
and legal department  
9. Quality Assurance and Regulatory Affairs (QARA):  
a. European software approval process and regulation (leading 
to CE mark)  
b. Differences between European and US (FDA) software 
approval roads and regulation.  
c. Current regulation for developing AI software as a medical 
device (MDR), both for commercial and in-house use  
d. Post market surveillance  
e. Further testing of such FDA/CE marked tools in a real clinical 
context  
f. Example of Health Technology Assessment (HTA) and risk 
analysis for a commercial AI solution 
g. Legal aspects and challenges in institutional, national and in-
ternational level 
Practical:  
◦ Workflow for software approval preparations (physicist 
perspective).  
◦ How to support hospital leadership and legal department for in- 
house developed software   
10. Ethical challenges in AI - in general and in healthcare  
a. Use case: Lessons learned from hospital ethics committee 
report and legal department  
b. Correct information of patients if AI software or predictive 
methods are used in clinical process  
c. Maintenance and archive of the original data, clinical data, 
synthetic data, and model used  
d. Use of chatbot and make decision systems based on AI for 
diagnostic and therapy, or for follow-up (virtual medical ex-
amination) and schedule of exams/therapy/surgery. (correct 
prioritization of the emergency or of the rescheduling) 
Practical:  
◦ Diagnostics of incurable neurological disease - the patient 
perspective: to know or not to know / or tougher: AI prognostics 
related to population demongraphics: link to healthcare 
prioritisation. 
ADVANCED LEVEL 
Note: All common advanced items refer specifically to AI applica-
tions and not to the conventional processes and corresponding methods. 
These common advanced AI items are utilised by all medical physics 
subspecialities (and modalities as applicable). 
Part I. Common to all sub-specialties  
1. Advanced QA on AI medical devices performance  
a. Implementation of QA protocol for AI testing in clinical practice; 
identify pitfalls and improvement opportunity  
b. Virtual clinical trials and hybrid data set generation for QA of AI 
tools  
c. QA on patient data 
2. AI for Image generation and restoration, including reconstruc-
tion, denoising and artifact reduction  
a. Benchmarking with conventional reconstruction methods  
i. Phantom and patient studies as a physical ground-truth 
reference  
ii. Technical and clinical (observer performance experiment) 
image quality measurements for clinical validation  
iii. Pitfalls and instabilities in AI-based reconstruction methods  
iv. Commercial and in-house developed methods 
3. Image processing, including localization, registration, seg-
mentation, quantitative analysis, and classification  
a. Popular tools, approaches and strategies 
b. Ground truth generation and QA (human generated segmenta-
tions and/or labels)  
c. Relevant metrics to validate AI performance: DICE, Hausdorff 
distance, etc.  
d. Accuracy and robustness validation, testing and QA  
4. AI protocol optimisation and radioprotection  
a. Procedure and treatment optimization  
i. Patient positioning and anatomical verification  
ii. Target and organs at risk (OAR) auto-contouring: validation 
and verification  
iii. Treatment/protocol guidance and automatic adaptation, dose 
tracking 
iv. Contrast or radiopharmaceutical use (inc. simulated proced-
ures on virtual phantoms)  
b. Patient dose registry applications archive management (AI 
automatization) and AI applications for dosimetry and risk 
management  
5. AI for workflow optimization and automation  
a. Management  
i. Workflow  
ii. Viewing protocols  
iii. Procedure/protocol appropriateness (justification)  
iv. Procedure duration 
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v. Patient informed consent procedure for trials/clinical practice 
(i.e. outcome prediction)  
b. Big data mining (enterprise imaging platforms and governance)  
6. Biomarkers and radiomics framework  
a. Extraction methods for biomarkers 
b. QA framework for biomarkers and radiomics (phantom and pa-
tient studies); harmonization for multicenter studies  
c. Validation and robustness of texture features  
d. Protocol and image quality effects of texture analysis: traceability 
and pitfalls  
e. Using biomarkers in predictive/prognostic models  
7. Regulatory roadmap of AI applications  
a. Steps (checklist) towards clinical/use clearance  
i. In-house AI methods  
ii. Research partnerships with industry (pre-FDA/CE mark 
process)  
b. Through worked-out examples: Checklist and related 
requirements  
i. Intended use definition  
ii. Risk analysis and classification  
iii. Validation and testing framework:  
◦ Definition of imaging/others protocols (input generation 
QA) 
◦ Image database requirements (data curation, clinical evi-
dence generation and ground truth definition  
◦ Statistical study power analysis  
◦ TRIPOD statement compliance  
◦ Data curation: patient/intended use case cohort 
description,  
◦ Robustness of performance and accuracy testing (patient/ 
phantom studies as required)  
iv. Testing generalization (robustness against databases from 
multiple protocols/vendors/models to generate input data)  
v. Post-market surveillance  
◦ Risk assessment and incident and accident prevention and 
reporting  
◦ FMEA/FMEAC (Failure mode and effect (and critically) 
analysis) in AI applications in radiology 
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